XML 25 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Net revenues
 9 Months Ended
Sep. 27, 2020
Revenue from Contract with Customer [Abstract]  
Net revenues Net revenuesWe primarily generate revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when our products are shipped from the manufacturing or distribution facility. For our Original Equipment and Development Services ("OEM") segment, most revenue is recognized over time because the OEM segment generates revenue from the sale of custom products that have no alternative use and we have an enforceable right to payment to the extent that performance has been completed. We market and sell products through our direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers such as pharmacies, which comprised 87%, 10% and 3% of consolidated net revenues, respectively, for the nine months ended September 27, 2020. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. With respect to the custom products sold in the OEM segment, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice.
The following table disaggregates revenue by global product category for the three and nine months ended September 27, 2020 and September 29, 2019.
Three Months EndedNine Months Ended
September 27, 2020September 29, 2019September 27, 2020September 29, 2019
(Dollars in thousands)
Vascular access$160,052 $148,681 $475,252 $446,225 
Anesthesia75,647 87,123 216,204 253,098 
Interventional93,187 106,883 275,704 314,852 
Surgical82,223 92,621 224,928 274,911 
Interventional urology81,773 73,629 196,114 201,312 
OEM49,399 55,444 168,618 166,110 
Other (1)
86,020 83,938 269,157 257,902 
Net revenues (2)
$628,301 $648,319 $1,825,977 $1,914,410 
(1) Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).
(2) The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.